233 related articles for article (PubMed ID: 8620461)
1. Analysis of nm23-H1 expression in breast cancer. Correlation with p53 expression and clinicopathologic findings.
Dueñas-González A; Abad-Hernández MM; García-Mata J; Paz-Bouza JI; Cruz-Hernández JJ; González-Sarmiento R
Cancer Lett; 1996 Mar; 101(2):137-42. PubMed ID: 8620461
[TBL] [Abstract][Full Text] [Related]
2. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.
Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE
Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493
[TBL] [Abstract][Full Text] [Related]
3. NM23 gene expression in human breast carcinomas: loss of correlation with cell proliferation in the advanced phase of tumor progression.
Caligo MA; Cipollini G; Berti A; Viacava P; Collecchi P; Bevilacqua G
Int J Cancer; 1997 Feb; 74(1):102-11. PubMed ID: 9036878
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer.
Tokunaga Y; Urano T; Furukawa K; Kondo H; Kanematsu T; Shiku H
Int J Cancer; 1993 Aug; 55(1):66-71. PubMed ID: 8102131
[TBL] [Abstract][Full Text] [Related]
5. Nm23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion.
Marone M; Scambia G; Ferrandina G; Giannitelli C; Benedetti-Panici P; Iacovella S; Leone A; Mancuso S
Br J Cancer; 1996 Oct; 74(7):1063-8. PubMed ID: 8855975
[TBL] [Abstract][Full Text] [Related]
6. Expression of nm23-H1 gene and Sialyl Lewis X antigen in breast cancer.
Yamaguchi A; Ding K; Maehara M; Goi T; Nakagawara G
Oncology; 1998; 55(4):357-62. PubMed ID: 9663428
[TBL] [Abstract][Full Text] [Related]
7. [The expression of nm23-H1 and p53 protein in nasopharyngeal carcinoma].
Zhou Y; Xu A; Ling X
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 Jun; 12(6):243-6. PubMed ID: 11189166
[TBL] [Abstract][Full Text] [Related]
8. P53 is a regulator of the metastasis suppressor gene Nm23-H1.
Chen SL; Wu YS; Shieh HY; Yen CC; Shen JJ; Lin KH
Mol Carcinog; 2003 Apr; 36(4):204-14. PubMed ID: 12669312
[TBL] [Abstract][Full Text] [Related]
9. Nm-23, c-erbB-2, and progesterone receptor expression in invasive breast cancer: correlation with clinicopathologic parameters.
Nakopoulou LL; Tsitsimelis D; Lazaris AC; Tzonou A; Gakiopoulou H; Dicoglou CC; Davaris PS
Cancer Detect Prev; 1999; 23(4):297-308. PubMed ID: 10403901
[TBL] [Abstract][Full Text] [Related]
10. Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma.
Tannapfel A; Köckerling F; Katalinic A; Wittekind C
Dis Colon Rectum; 1995 Jun; 38(6):651-4. PubMed ID: 7774480
[TBL] [Abstract][Full Text] [Related]
11. NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: an immunohistochemical study.
Sawan A; Lascu I; Veron M; Anderson JJ; Wright C; Horne CH; Angus B
J Pathol; 1994 Jan; 172(1):27-34. PubMed ID: 7931824
[TBL] [Abstract][Full Text] [Related]
12. [Low expression of nm23-H1 mRNA and its protein in breast cancer].
Guo W; Wang Y; Zhuang X; Bai Y; Zhang J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):91-3. PubMed ID: 10751528
[TBL] [Abstract][Full Text] [Related]
13. [Gastric cancer with P53 overexpression and nm23 low-expression has high potential for lymph node metastasis].
Zhang S; Ye S; Lin H
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):418-21. PubMed ID: 8697991
[TBL] [Abstract][Full Text] [Related]
14. Automated and quantitative immunocytochemical assays of Nm23/NDPK protein in breast carcinomas.
Charpin C; Bouvier C; Garcia S; Martini F; Andrac L; Lavaut MN; Allasia C
Int J Cancer; 1997 Aug; 74(4):416-20. PubMed ID: 9291431
[TBL] [Abstract][Full Text] [Related]
15. Expression of nm23-H1 gene product in esophageal squamous cell carcinoma and its association with vessel invasion and survival.
Tomita M; Ayabe T; Matsuzaki Y; Edagawa M; Maeda M; Shimizu T; Hara M; Onitsuka T
BMC Cancer; 2001; 1():3. PubMed ID: 11319942
[TBL] [Abstract][Full Text] [Related]
16. Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53.
Ambros RA; Vigna PA; Figge J; Kallakury BV; Mastrangelo A; Eastman AY; Malfetano J; Figge HL; Ross JS
Cancer; 1994 Mar; 73(6):1686-92. PubMed ID: 8156496
[TBL] [Abstract][Full Text] [Related]
17. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis.
Viel A; Dall'Agnese L; Canzonieri V; Sopracordevole F; Capozzi E; Carbone A; Visentin MC; Boiocchi M
Cancer Res; 1995 Jun; 55(12):2645-50. PubMed ID: 7780979
[TBL] [Abstract][Full Text] [Related]
18. Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis.
Yamaguchi A; Urano T; Fushida S; Furukawa K; Nishimura G; Yonemura Y; Miyazaki I; Nakagawara G; Shiku H
Br J Cancer; 1993 Nov; 68(5):1020-4. PubMed ID: 8217591
[TBL] [Abstract][Full Text] [Related]
19. Expression of nm23-H1 gene product in thyroid, ovary, and breast cancers.
Okubo T; Inokuma S; Takeda S; Itoyama S; Kinoshita K; Sugawara I
Cell Biophys; 1995 Jun; 26(3):205-13. PubMed ID: 8521452
[TBL] [Abstract][Full Text] [Related]
20. [nm23-H1 protein expression and its clinical significance in human laryngeal carcinoma].
Liang C; Xu G
Hua Xi Yi Ke Da Xue Xue Bao; 1999 Dec; 30(4):391-3. PubMed ID: 11387948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
